Efficacy of a Bilberry-based Probiotic Product on Glucose Tolerance and Insulin Resistance

Insulin Resistance Clinical Trial

Official title:

The Long Term Efficacy of a Bilberry-based Probiotic Product on Glucose Tolerance and Insulin Resistance as Compared to a Control.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03185676
• Other study ID #: InVeg (2)
• Status: Completed
• Phase: N/A
• First received: June 12, 2017
• Last updated: February 7, 2018
• Start date: May 2, 2017
• Est. completion date: November 30, 2017

Study information

• Verified date: February 2018
• Source: Lund University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The impact of a bilberry-based probiotic drink on the postprandial levels of serum glucose and insulin have already been study in the past. The aim of the current study is to evaluate the long term effect of the probiotic bilberry drink on glucose tolerance and insulin resistance in healthy adults and in comparison to a control drink.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 32
• Est. completion date: November 30, 2017
• Est. primary completion date: July 15, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

Healthy adults with a BMI between 20-30

Exclusion Criteria:

Related Conditions & MeSH terms

• Insulin Resistance

Intervention

Other:
• Bilberry
A bilberry based probiotic beverage
• beverage without bilberries or probiotics
A control beverage without bilberries or probiotics

Locations

Country	Name	City	State
Sweden	Klinisk Prövningsenhet, Kliniska Studier Sverige - Forum Söder	Lund

Sponsors (1)

Lead Sponsor	Collaborator
Lund University

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The long term effect of a bilberry-based probiotic beverage on postprandial levels of serum insulin	The incremental area under the curve (AUC) will be measured for the levels of postprandial serum insuling from 0 min to 120 min following ingestion of the product (included intermediate measuring time points are 30, 60 and 90 min)	Incremental area under the curve for serum insulin from 0 min up to 120 min following the ingestion of the study product